ஹைதராபாத் மையம் க்கு செல்லுலார் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹைதராபாத் மையம் க்கு செல்லுலார். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹைதராபாத் மையம் க்கு செல்லுலார் Today - Breaking & Trending Today

Patanjali researchers were the first to published a study on 2-Deoxy-D-Glucose which is now approved by DCGI.

by Bhaswati Guha Majumder - May 10, 2021 05:28 AM
Yoga guru Ramdev and Patanjali CEO Balkrishna
Snapshot
Researchers from Patanjali Research Institute, along with experts from Vivekanand Education Societyâs Institute of Technology and Jain Vishva Bharati Institute, published their findings in 2020.
With the country battling the second wave of coronavirus, the Drugs Controller General of India (DCGI) on 8 May approved a drug for emergency use.
The drug is 2-deoxy-D-glucose (2-DG) which has been approved as an adjunct therapy in moderate-to-severe Covid-19 cases.
Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty, said the Defence Research and Development Organisation (DRDO). ....

Uttar Pradesh , Andhra Pradesh , Tamil Nadu , Jain Vishva Bharati Institute , Vivekanand Education Society Institute Of Technology , Institute Of Nuclear Medicine , Patanjali Research Institute , Development Organisation , Hyderabad Centre For Cellular , Defence Research , Drugs Controller General , Nuclear Medicine , Allied Sciences , Hyderabad Based Dr Reddy , Molecular Biology , West Bengal , Vivekanand Education Society , உத்தர் பிரதேஷ் , ஆந்திரா பிரதேஷ் , தமிழ் நாடு , விவேகானந்த் கல்வி சமூகம் நிறுவனம் ஆஃப் தொழில்நுட்பம் , நிறுவனம் ஆஃப் அணு மருந்து , பதஞ்சலி ஆராய்ச்சி நிறுவனம் , வளர்ச்சி ஆர்கநைஸேஶந் , ஹைதராபாத் மையம் க்கு செல்லுலார் , பாதுகாப்பு ஆராய்ச்சி ,

'There are so many hurdles.' Indian scientists plead with government to unlock COVID-19 data | Science

Share
People wait in line to receive the COVID-19 vaccine in Mumbai, India, on 29 April.
AP Photo/Rajanish Kakade
‘There are so many hurdles.’ Indian scientists plead with government to unlock COVID-19 data
May. 4, 2021 , 12:10 PM
Reporting for this story was supported by a journalism grant from the Thakur Family Foundation, which has not influenced the contents of this report.
Indian researchers say they urgently need better access to data collected by government agencies to help them understand and fight the country’s devastating second pandemic wave. An open letter published on 29 April that has 740 signatories so far asks the government for access to databases on COVID-19 testing and genomic sequencing and urges it to remove other obstacles to research. ....

United States , Andhra Pradesh , Tamil Nadu , United Kingdom , Rakesh Mishra , Gagandeep Kang , Partha Pratim Majumder , Rajanish Kakade , K Vijay Raghavan , Indian Institute Of Science Education , Indian Council Of Medical Research , Hyderabad Centre For Cellular , Office Of The Principal Scientific Adviser , Thakur Family Foundation , Christian Medical College , Consortium On Genomics , National Institute Of Biomedical Genomics , National Institute , Biomedical Genomics , West Bengal , Principal Scientific Adviser , Indian Council , Medical Research , Indian Institute , Science Education , Molecular Biology ,

Is 'Atmanirbhar Bharat' Holding Up India's Genome Sequencing Program?

Is Atmanirbhar Bharat Holding Up India s Genome Sequencing Program?
India s newly launched programme to widely and rapidly sequence genomes of the novel coronavirus has already run into major hurdles.
Illustration: ColiN00B/pixabay
Bengaluru: Rakesh Mishra, the director of Hyderabad’s Centre for Cellular and Molecular Biology (CCMB), is frustrated. CCMB has been sequencing SARS-CoV-2 viral genomes since the COVID-19 pandemic began â initially as part of its own research program and since December 2020 as part of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a group of ten labs the government put together to ramp up sequencing across to India.
To do its work, Mishra’s team needs specialised plastic containers and reagents that go into sequencing machines. But buying them has become needlessly complicated in the last year, taking time away from his lab’s core jobs, according to Mishra. ....

United Kingdom , New Delhi , South Africa , Uttar Pradesh , Andhra Pradesh , Ravi Vasanthapuram , Utkarsh Betodkar , Uma Ramakrishnan , Sujeet Kumar Singh , Vinod Scaria , Tirumala Bharanik Settypalli , Rakesh Mishra , Divya Tej Sowpati , Rajesh Bhaskar , Murali Dharan Bashyam , Anurag Agarwal , Renu Swarup , National Centre For Biological Sciences , Institute Of Genomics , Hyderabad Centre For Cellular , Health Laboratory , Bj Medical College , National Institute Of Mental Health , National Institute Of Virology , Division Of Nuclear Techniques In Food , National Centre For Cell Science ,

Covid-19: India reports new UK variant of coronavirus. How dangerous is it?

Covid-19: India reports new UK variant of coronavirus. How dangerous is it?
Covid-19: India reports new UK variant of coronavirus. How dangerous is it?
Six of the passengers returning from the UK have tested positive for the new variant of SARS-CoV-2 that causes Covid-19. This comes at a time when India has started reporting fresh cases at a level it reported back in June. How to take entry of new variant of coronavirus in India?
advertisement
UPDATED: December 29, 2020 14:45 IST
A devotee wearing face mask amid concern over spread of new variant of coronavirus attends mid-night Christmas mass in Chennai. (Photo: PTI) ....

Andhra Pradesh , United Kingdom , Union Territories Of India , Pune National Institute Of Virology , Hyderabad Centre For Cellular , Molecular Biology , National Institute , Union Territories , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , தொழிற்சங்கம் பிரதேசங்கள் ஆஃப் இந்தியா , புனே தேசிய நிறுவனம் ஆஃப் வைராலஜி , ஹைதராபாத் மையம் க்கு செல்லுலார் , மூலக்கூறு உயிரியல் , தேசிய நிறுவனம் , தொழிற்சங்கம் பிரதேசங்கள் ,